Cost Effectiveness Analysis of Tapentadol PR Versus Oxycodone/Naloxone PR in Patients with Musculoskeletal Pain in Spain
Cost of Patients with Alzheimer’s Disease in Spain According to Disease Severity
Coste-efectividad de la polipíldora CNIC frente a los monocomponentes separados en prevención secundaria cardiovascular en España
Strategic discussion on funding and access to therapies targeting rare diseases in Spain: an expert consensus paper
Efficacy, Effectiveness, and Safety of Ustekinumab for the Treatment of Ulcerative Colitis: A Systematic Review
The social value of a PASI 90 or PASI 100 response in patients with moderate-to-severe plaque psoriasis in Spain
Cost-benefit analysis of ALK diagnosis vs. non-diagnosis in patients with advanced non–small cell lung cancer in Spain
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases
A Social Return on Investment Analysis of Improving the Management of Chronic Obstructive Pulmonary Disease Within the Spanish National Healthcare System
Análisis de las estrategias dirigidas a aumentar la cobertura de vacunación antigripal en personas de 65 años y más
